http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007089562-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b31d075d8534fde957ca7df26020eb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96106031c4eab3cb4464775e64ef1c8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1d40c6ee565197ac31bd7de652563bf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
filingDate 2007-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6582db2c4ab11d330f43b7ee696ea1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6821ecde4f4552b4637f7d70b276675
publicationDate 2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007089562-A3
titleOfInvention Compositions and methods for the treatment of viral infections
abstract The present invention provides compositions and methods for inhibiting the replication of influenza virus by administering thiophosphonoformic acid alone or in combination with a neuraminidase inhibitor, for example, oseltamivir.
priorityDate 2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6444837-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6777420-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226418781

Total number of triples: 20.